Correlation Between Dr Reddys and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and TG Therapeutics, you can compare the effects of market volatilities on Dr Reddys and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and TG Therapeutics.

Diversification Opportunities for Dr Reddys and TG Therapeutics

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between RDY and TGTX is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Dr Reddys i.e., Dr Reddys and TG Therapeutics go up and down completely randomly.

Pair Corralation between Dr Reddys and TG Therapeutics

Considering the 90-day investment horizon Dr Reddys is expected to generate 2.31 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, Dr Reddys Laboratories is 4.08 times less risky than TG Therapeutics. It trades about 0.07 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,898  in TG Therapeutics on August 31, 2024 and sell it today you would earn a total of  582.00  from holding TG Therapeutics or generate 20.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dr Reddys Laboratories  vs.  TG Therapeutics

 Performance 
       Timeline  
Dr Reddys Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
TG Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dr Reddys and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dr Reddys and TG Therapeutics

The main advantage of trading using opposite Dr Reddys and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Dr Reddys Laboratories and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account